Inhibition of TNF-α/IFN-γ induced RANTES expression in HaCaT cell by naringin

Pharmaceutical Biology

Volumn 49, Issue 8, 2011, Pages 810-814

  Si Si, Wang ^a   Liao, Liu ^b   Ling, Zhu ^a   Yun Xia, Yang ^a  

^a SICHUAN UNIVERSITY   (China)

^b Department of Pharmacy   (China)

Author keywords

HaCaT cells; IFN ; Naringin; NF B; RANTES; TNF

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; AURANTIIN; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; RANTES; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL NUCLEUS; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; HUMAN; HUMAN CELL; PROTEIN EXPRESSION;

ANTI-INFLAMMATORY AGENTS; CELL PROLIFERATION; CHEMOKINE CCL5; CITRUS; EPITHELIAL CELLS; FLAVANONES; HUMANS; INFLAMMATION; INTERFERON-GAMMA; KERATINOCYTES; NF-KAPPA B; PHYTOTHERAPY; PLANT PREPARATIONS; TETRAZOLIUM SALTS; THIAZOLES; TUMOR NECROSIS FACTOR-ALPHA;

CITRUS; CITRUS JUNOS; CITRUS RETICULATA; CITRUS SINENSIS; CITRUS TACHIBANA; CITRUS UNSHIU; CITRUS X PARADISI; RUTACEAE;

EID: 79959619519     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.3109/13880209.2010.550054     Document Type: Article

References (19)

1. Benavente-García O, Castillo J. (2008). Update on uses and properties of citrus flavonoids: New findings in anticancer, cardiovascular, and anti-inflammatory activity. J Agric Food Chem, 56, 6185-6205.
2. Castillo J, Benavente O, Del Río JA. (1992). Naringin and neohesperidin levels during development of leaves, flower buds, and fruits of Citrus aurantium. Plant Physiol, 99, 67-73.
3. Chen JC, Li LJ, Wen SM, He YC, Liu HX, Zheng QS. (2009). [Antiinflammatory effects and quantitative study of the combinations of active ingredients of Painong powder in mice]. Zhong Xi Yi Jie He Xue Bao, 7, 541-545.
4. Fujisawa H, Kondo S, Wang B, Shivji GM, Sauder DN. (1997). The expression and modulation of IFN-alpha and IFN-beta in human keratinocytes. J Interferon Cytokine Res, 17, 721-725. (Pubitemid 28027984)
5. Fukuoka M, Ogino Y, Sato H, Ohta T, Komoriya K, Nishioka K, Katayama I. (1998). RANTES expression in psoriatic skin, and regulation of RANTES and IL-8 production in cultured epidermal keratinocytes by active vitamin D3 (tacalcitol). Br J Dermatol, 138, 63-70. (Pubitemid 28077939)
6. Homey B, Meller S, Savinko T, Alenius H, Lauerma A. (2007). Modulation of chemokines by staphylococcal superantigen in atopic dermatitis. Chem Immunol Allergy, 93, 181-194. (Pubitemid 46924878)
7. Jourdan PS, Weiler EW, Mansell RL. (1985). Naringin levels in citrus tissues: I. Comparison of different antibodies and tracers for the radioimmunossay of naringin. Plant Physiol, 77, 896-902.
8. Krueger JG, Bowcock A. (2005). Psoriasis pathophysiology: Current concepts of pathogenesis. Ann Rheum Dis, 64 (Suppl 2), ii30-ii36. (Pubitemid 40288517)
9. Limasset B, le Doucen C, Dore JC, Ojasoo T, Damon M, Crastes de Paulet A. (1993). Effects of flavonoids on the release of reactive oxygen species by stimulated human neutrophils. Multivariate analysis of structure-activity relationships (SAR). Biochem Pharmacol, 46, 1257-1271. (Pubitemid 23306748)
10. Luger TA, Schwarz T. (1990). Evidence for an epidermal cytokine network. J Invest Dermatol, 95, 100S-104S.
11. Mezzano S, Aros C, Droguett A, Burgos ME, Ardiles L, Flores C, Schneider H, Ruiz-Ortega M, Egido J. (2004). NF-kappaB activation and overexpression of regulated genes in human diabetic nephropathy. Nephrol Dial Transplant, 19, 2505-2512. (Pubitemid 39360096)
12. Moriuchi H, Moriuchi M, Fauci AS. (1997). Nuclear factor-kappa B potently up-regulates the promoter activity of RANTES, a chemokine that blocks HIV infection. J Immunol, 158, 3483-3491. (Pubitemid 127484070)
13. Oppenheim JJ, Zachariae CO, Mukaida N, Matsushima K. (1991). Properties of the novel proinflammatory supergene "intercrine" cytokine family. Annu Rev Immunol, 9, 617-648.
14. Pasparakis M, Courtois G, Hafner M, Schmidt-Supprian M, Nenci A, Toksoy A, Krampert M, Goebeler M, Gillitzer R, Israel A, Krieg T, Rajewsky K, Haase I. (2002). TNF-mediated inflammatory skin disease in mice with epidermis-specific deletion of IKK2. Nature, 417, 861-866. (Pubitemid 34670334)
15. Pattison JM, Nelson PJ, Krensky AM. (1995). The RANTES chemokine: A new target for immunomodulatory therapy? Clin Immunother, 4, 1-8.
16. Raychaudhuri SP, Jiang WY, Farber EM, Schall TJ, Ruff MR, Pert CB. (1999). Upregulation of RANTES in psoriatic keratinocytes: A possible pathogenic mechanism for psoriasis. Acta Derm Venereol, 79, 9-11. (Pubitemid 29079320)
17. Schall TJ. (1991). Biology of the RANTES/SIS cytokine family. Cytokine, 3, 165-183.
18. Tsai SH, Lin-Shiau SY, Lin JK. (1999). Suppression of nitric oxide synthase and the down-regulation of the activation of NFkappaB in macrophages by resveratrol. Br J Pharmacol, 126, 673-680.
19. Zhang M, Zhu L, Feng Y, Yang Y, Liu L, Ran Y. (2008). Effects of acitretin on proliferative inhibition and RANTES production of HaCaT cells. Arch Dermatol Res, 300, 575-581.